Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. - An international pharmaceutical company engaged in the development and sale of prescription and over-the-counter pharmaceuticals.

Valeant specializes in the manufacture of drugs in the field of dermatology, neurology and ophthalmology. The company considers its priority markets the United States of America, Canada, Mexico, Brazil, Central and Eastern Europe, Australia, Southeast Asia and South Africa.

Facts:

• Over 22,000 employees worldwide;
• Exchange / Code - NYSE / TSX: VRX;
• Headquarters in Laval, Canada;
• A wide portfolio of products, including, above all, original / branded drugs, branded generics and over-the-counter drugs;
• Main specializations: dermatology and ophthalmology;
• Key sales areas are North America, Europe and the Middle East, Latin America, Asia Pacific and South Africa;
• Production sites in Canada, Brazil, Poland and Mexico;
• Areas of competence: regulatory field and medicine.

International presence

International company Valeant Pharmaceuticals International, Inc. It is represented mainly in five macro-regions: in the USA, Canada, Australia, Latin America, Central and Eastern Europe. Each of these regions has its own market focus, and a special assortment of prescription brands, branded generics and over-the-counter drugs is popular in each.